COVID-19 vaccines for patients with haematological conditions

Commentary notes most of this patient group would have been ineligible for the trials and until COVID-19 vaccines (CV19V) have been rigorously studied in this population, reference to immune response to CV19 infection & non-CV19 vaccines will be needed to inform clinical practice

Source:

The Lancet Haematology